PreveCeutical Medical (PRVCF) Stock Statistics & Valuation Metrics

PreveCeutical Medical has a market cap or net worth of $16.62M. The enterprise value is $21.71M.

PreveCeutical Medical has 570,649,500 shares outstanding. The number of shares has decreased by -2.65% in one year.

PreveCeutical Medical’s return on equity (ROE) is <0.01 and return on invested capital (ROIC) is 37.33%.

The current PE Ratio of {name} is {pe}. {name}’s PEG ratio is {priceToEarningsGrowthRatio}.

In the last 12 months, PreveCeutical Medical had revenue of 0.00 and earned -1.17K in profits. Earnings per share was 0.00.

In the last 12 months, operating cash flow was -472.63K and capital expenditures -58.48K, giving a free cash flow of -531.12K billion.

PreveCeutical Medical pays an annual dividend of ―, resulting in a dividend yield of ―

PreveCeutical Medical upcoming earnings date is ―, ―.

PreveCeutical Medical as a current ratio of 0.02, with Debt / Equity ratio of -63.69%

In the past 12 months, PreveCeutical Medical has paid 0.00 in taxes.

PreveCeutical Medical EV to EBITDA ratio is -5.95K, with an EV/FCF ratio of -10.30.

PreveCeutical Medical has $5.47K in cash and marketable securities with C$4.60M in debt, giving a net cash position of $4.59M billion.

Gross margin is 0.00%, with operating margin of 0.00%, and net profit margin of 0.00%.

The average price target for PreveCeutical Medical is ―, which is 11.43% higher than the current price. The consensus rating is ―